azacitidine has been researched along with Intestinal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akemoto, Y; Chinda, D; Fukuda, S; Hasui, K; Hiraga, H; Ishiguro, Y; Kamata, K; Kikuchi, H; Kishida, D; Maeda, T; Mayama, K; Mikami, T; Murai, Y; Ota, S; Sakuraba, H; Sawaya, M; Tanaka, M; Tanaka, N; Tatsuta, T; Watanabe, R; Yamagata, K | 1 |
| Hashimoto, S; Kawajiri, C; Nakaseko, C; Ohwada, C; Sakai, S; Sakaida, E; Shimizu, N; Takagi, T; Takeda, Y; Takeuchi, M; Tanaka, H; Tougasaki, E | 1 |
2 other study(ies) available for azacitidine and Intestinal Diseases
| Article | Year |
|---|---|
Long-term maintenance of the mucosal healing induced by azacitidine therapy in a patient with intestinal Behçet's-like disease accompanied with myelodysplastic syndrome involving trisomy 8.
Topics: Azacitidine; Behcet Syndrome; Chromosomes, Human, Pair 8; Female; Humans; Intestinal Diseases; Maintenance Chemotherapy; Middle Aged; Myelodysplastic Syndromes; Time Factors; Treatment Outcome; Trisomy | 2019 |
Successful treatment by azacitidine therapy of intestinal Behçet's disease associated with myelodysplastic syndrome.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Behcet Syndrome; Bone Marrow; Colonoscopy; Humans; Intestinal Diseases; Intestines; Male; Middle Aged; Myelodysplastic Syndromes; Treatment Outcome | 2013 |